1,2-dimethylhydrazine has been researched along with metformin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moustafa, YM; Zaafar, DK; Zaitone, SA | 1 |
| Anisimov, VN; Bekusova, VV; Nozdrachev, AD; Patsanovskii, VM | 1 |
| Bordini, HP; Cecchini, AL; Conchon-Costa, I; da Silva, SS; Fagundes, TR; Kremer, JL; Luiz, RC; Melo, GP; Panis, C | 1 |
3 other study(ies) available for 1,2-dimethylhydrazine and metformin
| Article | Year |
|---|---|
Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation.
Topics: 1,2-Dimethylhydrazine; Animals; Antigens, CD34; Antineoplastic Agents; Cell Proliferation; Colon; Colonic Neoplasms; Diabetes Mellitus, Experimental; Diet, High-Fat; Drug Therapy, Combination; Hypoglycemic Agents; Insulin-Like Growth Factor I; Male; Metformin; Mice; Neovascularization, Pathologic; Organoplatinum Compounds; Oxaliplatin; Receptor, IGF Type 1; Survival Rate; Vascular Endothelial Growth Factor A | 2014 |
Metformin inhibits development of colon malignant tumors induced by 1,2-dimethylhydrazine in rats.
Topics: 1,2-Dimethylhydrazine; Animals; Colonic Neoplasms; Dose-Response Relationship, Drug; Male; Metformin; Rats; Rats, Wistar | 2016 |
Protective effect of metformin in an aberrant crypt foci model induced by 1,2-dimethylhydrazine: Modulation of oxidative stress and inflammatory process.
Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Colorectal Neoplasms; Female; Metformin; Mice; Neoplasms, Experimental; Oxidative Stress; Signal Transduction; Treatment Outcome | 2017 |